Pericapsular Nerve Group Block Chemical Neurolysis in Advanced Hip Osteoarthritis

• Status: Recruiting
• Trial end date: 2024-05-28
• Target enrollment: 0
• Participant gender: All

Summary

PENG neurolysis in advanced osteoarthritis of the hip joint.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Poznan University of Medical Sciences
• Treatments: Ethanol

Criteria

Inclusion Criteria:

• Patients of the Pain Treatment Clinic of the Transfiguration of Jesus Clinical Hospital of the Medical University of Poznań will be qualified for the study

• patients with coxarthrosis or gonarthrosis who failed to achieve satisfactory pain control (NRS>3) despite the use of NSAIDs, Paracetamol, and co-analgetics

• Age of patients: from 18 to 110 years of age.

• Caucasian patients can give informed, complete, written consent.

Exclusion Criteria:

• suspected or diagnosed opioid dependence syndrome

• active cancer

• dementia